Publication | Open Access

The impact of selenium on regulatory T cell frequency and immune checkpoint receptor expression in patients with diffuse large B cell lymphoma (DLBCL)

Lymphoid NeoplasiaMedicineMalignant Blood DisorderImmunologyPathologyImmune Checkpoint InhibitorAutoimmunityAdult T-cell Leukemia-lymphomaImmunotherapyOncologyTumor Microenvironment